Publikationen in Zusammenarbeit mit Forschern von Queen's University (16)

2023

  1. Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022

    Annals of Oncology, Vol. 34, Núm. 1, pp. 48-60

2022

  1. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  2. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis

    BMC Pulmonary Medicine, Vol. 22, Núm. 1

  3. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851

2021

  1. Building capacity for palliative care delivery in primary care settings Mixed-methods evaluation of the INTEGRATE Project

    Canadian Family Physician, Vol. 67, Núm. 4, pp. 270-278

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  4. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

2019

  1. Integrating early palliative care into routine practice for patients with cancer: A mixed methods evaluation of the INTEGRATE Project

    Psycho-Oncology, Vol. 28, Núm. 6, pp. 1261-1268

2018

  1. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

    The Lancet, Vol. 391, Núm. 10137, pp. 2325-2334

  2. OV21/PETROC: A randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

    Annals of Oncology, Vol. 29, Núm. 2, pp. 431-438

  3. OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

    Obstetrical and Gynecological Survey

2017

  1. Oncology nurses' attitudes toward the Edmonton symptom assessment system: Results from a large cancer care Ontario study

    Oncology Nursing Forum, Vol. 44, Núm. 1, pp. 116-125

2016

  1. Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada

    Journal of Pain and Symptom Management

  2. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): A randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet, Vol. 387, Núm. 10023, pp. 1066-1074

2014

  1. Population-based standardized symptom screening: Cancer Care Ontario's edmonton symptom assessment system and performance status initiatives

    Journal of Oncology Practice, Vol. 10, Núm. 3, pp. 212-214